Catalyst
Slingshot members are tracking this event:
Phase 2/3 data of RG7916 in Spinal Muscular Atrophy (SMA) to be presented at AAN May 7, 2019 1pm.
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 07, 2019
Occurred Source:
http://ir.ptcbio.com/news-releases/news-release-details/data-pivotal-firefish-and-sunfish-studies-demonstrate-clinical
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 2/3, Rg7916, Spinal Muscular Atrophy